AirSculpt Technologies, Inc. Announces Special Dividend
August 12 2022 - 6:00AM
The Board of Directors of AirSculpt Technologies, Inc.
(NASDAQ:AIRS)(“AirSculpt” or the “Company”) today declared a
special dividend of $0.41 per share special cash dividend. The
dividend will be paid on September 14, 2022, to shareholders of
record at the close of business on August 26, 2022.
“We are pleased to announce this return of capital to
shareholders,” said Adam Feinstein, Chairman of the Board of
Directors. “Our Board’s approval of the special dividend reflects
our confidence in the Company’s long-term growth potential and
strong balance sheet, allowing us to pay a dividend to shareholders
from excess cash from operations, while maintaining financial and
operational flexibility to continue to grow our business over the
long term.”
About AirSculpt
Technologies
AirSculpt Technologies is an experienced,
fast-growing national provider of body contouring procedures
delivering a premium consumer experience under its brand, Elite
Body Sculpture. At Elite Body Sculpture, we provide custom body
contouring using our proprietary AirSculpt® method that removes
unwanted fat in a minimally invasive procedure, producing dramatic
results. It is our mission to generate the best results for our
patients.
Forward-Looking Statements
This press release contains forward-looking
statements. In some cases, you can identify these statements by
forward-looking words such as “may,” “might,” “will,” “should,”
“expects,” “plans,” “anticipates,” “believes,” “estimates,”
“predicts,” “potential” or “continue,” the negative of these terms
and other comparable terminology. These forward-looking statements,
which are subject to risks, uncertainties and assumptions about us,
may include projections of our future financial performance, our
anticipated growth strategies and anticipated trends in our
business. These statements are only predictions based on our
current expectations and projections about future events. There are
important factors that could cause our actual results, level of
activity, performance or achievements to differ materially from the
results, level of activity, performance or achievements expressed
or implied by the forward-looking statements, including those
factors discussed in the section titled “Risk Factors” in our
Registration Statement (Registration No. 333-260067) on Form S-1
and in periodic reports on Form 10-K and Form 10-Q.
Our future results could be affected by a
variety of other factors, including, but not limited to, failure to
open and operate new centers in a timely and cost-effective manner;
shortages or quality control issues with third-party manufacturers
or suppliers; competition for surgeons; litigation or medical
malpractice claims; inability to protect the confidentiality of our
proprietary information; changes in the laws governing the
corporate practice of medicine or fee-splitting; changes in the
regulatory, economic and other conditions of the states and
jurisdictions where our facilities are located; and business
disruption or other losses from war, pandemic, terrorist acts or
political unrest.
The risk factors discussed in “Risk Factors” in
our Registration Statement (Registration No. 333-260067) on Form
S-1 and in our periodic reports on Form 10-K and Form 10-Q could
cause our results to differ materially from those expressed in the
forward-looking statements made in this Press Release.
There also may be other risks that are currently unknown to us
or that we are unable to predict at this time.
Although we believe the expectations reflected
in the forward-looking statements are reasonable, we cannot
guarantee future results, level of activity, performance or
achievements. Moreover, neither we nor any other person assumes
responsibility for the accuracy and completeness of any of these
forward-looking statements. Forward-looking statements speak only
as of the date they were made, and we are under no duty to update
any of these forward-looking statements after the date of this
press release to conform our prior statements to actual results or
revised expectations.
Investor Contact: Dennis Dean, Chief Financial
Officerinvestors@elitebodysculpture.com
AirSculpt Technologies (NASDAQ:AIRS)
Historical Stock Chart
From Aug 2024 to Sep 2024
AirSculpt Technologies (NASDAQ:AIRS)
Historical Stock Chart
From Sep 2023 to Sep 2024